REV7 counteracts DNA double-strand break resection and affects PARP inhibition
暂无分享,去创建一个
Peter Bouwman | Jiri Bartek | Kees Jalink | Jos Jonkers | Bram van den Broek | Piet Borst | Jingsong Yuan | J. Bartek | J. Bártková | P. Borst | Junjie Chen | S. Boulton | J. Jonkers | E. Gogola | S. Rottenberg | K. Jalink | Guotai Xu | D. Gent | P. Schouten | B. V. D. Broek | M. Nieuwland | J. R. Chapman | P. Celie | M. Mistrik | Jirina Bartkova | Dik C. van Gent | Junjie Chen | Martin Mistrik | Jingsong Yuan | P. Bouwman | Mark Pieterse | A. Kersbergen | Kenji Watanabe | Janneke E. Jaspers | Ariena Kersbergen | Wendy Sol | Sven Rottenberg | Mark Pieterse | Marja Nieuwland | Simon J. Boulton | Ewa Gogola | Marco Barazas | J. Ross Chapman | Kenji Watanabe | Philip C. Schouten | Inger Brandsma | J. Jaspers | Guotai Xu | Daniël Warmerdam | Patrick H. N. Celie | Ahmed Salman | Iris de Rink | Jorma de Ronde | W. Sol | I. Brandsma | I. D. Rink | M. Barazas | Ahmed Salman | Daniël O. Warmerdam | J. D. Ronde | Marja Nieuwland
[1] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[2] Facundo D. Batista,et al. RIF1 Is Essential for 53BP1-Dependent Nonhomologous End Joining and Suppression of DNA Double-Strand Break Resection , 2013, Molecular cell.
[3] R. Wood,et al. DNA polymerase zeta (pol ζ) in higher eukaryotes , 2008, Cell Research.
[4] A. Ashworth,et al. Efficacy of Chemotherapy in BRCA1/2 Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study , 2013, Clinical Cancer Research.
[5] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[6] A. Lau,et al. Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin , 2008, Clinical Cancer Research.
[7] Shridar Ganesan,et al. Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors. , 2013, Cancer discovery.
[8] Michael M. Murphy,et al. Polζ ablation in B cells impairs the germinal center reaction, class switch recombination, DNA break repair, and genome stability , 2009, The Journal of experimental medicine.
[9] Y. Murakumo,et al. Crystal Structure of Human REV7 in Complex with a Human REV3 Fragment and Structural Implication of the Interaction between DNA Polymerase ζ and REV1* , 2010, The Journal of Biological Chemistry.
[10] J. Sale,et al. Sequestration of CDH1 by MAD2L2 prevents premature APC/C activation prior to anaphase onset , 2013, The Journal of cell biology.
[11] D. Adams,et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers , 2010, Nature Structural &Molecular Biology.
[12] E. Kohn,et al. PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] H. Yamanishi,et al. A Missense Mutation in Rev7 Disrupts Formation of Polζ, Impairing Mouse Development and Repair of Genotoxic Agent-induced DNA Lesions* , 2013, The Journal of Biological Chemistry.
[14] Toshiyuki Shimizu,et al. Structural basis of recruitment of DNA polymerase ζ by interaction between REV1 and REV7 proteins. , 2012, The Journal of biological chemistry.
[15] D. Durocher,et al. 53BP1 is a reader of the DNA damage-induced H2A Lys15 ubiquitin mark , 2013, Nature.
[16] S. Powell,et al. BRCA1 and BRCA2: different roles in a common pathway of genome protection , 2011, Nature Reviews Cancer.
[17] Alan Ashworth,et al. Mechanisms of resistance to therapies targeting BRCA-mutant cancers , 2013, Nature Medicine.
[18] B. Blagoev,et al. JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1–mediated chromatin response to DNA breaks , 2013, Nature Structural &Molecular Biology.
[19] Jeremy M. Stark,et al. 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks , 2010, Cell.
[20] Jiri Bartek,et al. Human CtIP promotes DNA end resection , 2007, Nature.
[21] R. Kanaar,et al. DNA-binding and strand-annealing activities of human Mre11: implications for its roles in DNA double-strand break repair pathways. , 2001, Nucleic acids research.
[22] K. Kok,et al. REV7 is required for anaphase-promoting complex-dependent ubiquitination and degradation of translesion DNA polymerase REV1 , 2013, Cell cycle.
[23] Ellen Fanning,et al. A dynamic model for replication protein A (RPA) function in DNA processing pathways , 2006, Nucleic acids research.
[24] Edward S. Miller,et al. The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage , 2009, Cell.
[25] T. Ørntoft,et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.
[26] Peter Bouwman,et al. A high-throughput functional complementation assay for classification of BRCA1 missense variants. , 2013, Cancer discovery.
[27] Michal Zimmermann,et al. 53BP1: pro choice in DNA repair. , 2014, Trends in cell biology.
[28] J. Aten,et al. Induction of linear tracks of DNA double-strand breaks by α-particle irradiation of cells , 2008, Nature Methods.
[29] J. Ellenberg,et al. RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins , 2009, Cell.
[30] L. Thompson,et al. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. , 1999, Genes & development.